- About Us
- What We Do
- How We Heal
- Products
- Cartilage Repair Device
- Medeor® Matrix for Soft Tissue Repair
- Meso BioMatrix® Scaffold for Soft Tissue Repair
- Epi-Guide® Bioresorbable Barrier Matrix
- OsseoFit™ Porous Tissue Matrix™
- Vitoss® Scaffold Foam™ Products
- Angio-Seal™ Vascular Closure Device
- QuickCat™ Extraction Catheter
- ThromCat® Thrombectomy System
- Technology Platforms
- How We Partner
- Investor Relations
Commercialization and Process Validation
Commercialization
Kensey Nash's expertise in product development extends through product launch and commercialization. Our development, manufacturing and quality teams coordinate to scale-up pilot manufacturing processes to meet commercial volume expectations, whether the demand is a thousand units or hundreds of thousands of units. Project leaders with both technical and project management skills facilitate the commercialization process.
Process Validation
We conduct rigorous process validations to ensure the commercial production operations are properly qualified before releasing products for commercial use. These activities ensure that the products that reach the market maintain the original design requirements. Our partners can have the utmost confidence that Kensey Nash will deliver quality parts with speed and precision.
- About Us
- What We Do
- How We Heal
- Products
- Cartilage Repair Device
- Medeor® Matrix for Soft Tissue Repair
- Meso BioMatrix® Scaffold for Soft Tissue Repair
- Epi-Guide® Bioresorbable Barrier Matrix
- OsseoFit™ Porous Tissue Matrix™
- Vitoss® Scaffold Foam™ Products
- Angio-Seal™ Vascular Closure Device
- QuickCat™ Extraction Catheter
- ThromCat® Thrombectomy System
- Technology Platforms
- How We Partner
- Investor Relations

